Plain-English translation of NCT06815354 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a software tool called TRAQinform Theranostics that analyzes medical images to help doctors understand how well Pluvicto (a nuclear medicine treatment) is working against advanced prostate cancer. The software compares your imaging scans over time and helps doctors decide whether to continue treatment or make changes. The study will follow 32 patients with advanced prostate cancer who are starting this medication.
Doctors need better ways to quickly and accurately see whether this medication is helping patients and detect any problems early. This trial wants to know if the new software can improve treatment decisions by giving doctors clearer information from imaging scans.
You will have two imaging appointments: one before starting treatment and another at 12 weeks into your treatment. At each visit, you'll receive a PET scan and a CT scan to look at how your cancer is responding. Your doctors will review these images and make treatment decisions twice—once without the software analysis and once with it—to see whether the new tool would have changed their recommendations. The study lasts about 12 weeks from your baseline imaging visit.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
United States